August MIMS update

We look at some of the recent changes to the medicines landscape, with new products, new indications, contraindications and more New Products Avatrombopag (as maleate) (Doptelet) is an orally bioavailable, small molecule thrombopoietin receptor (TPO-R) agonist. It stimulates proliferation and differentiation of megakaryocytes from bone marrow progenitor cells, resulting in an increased production of platelets.